Propanc Biopharma (PPCB)

• Market cap: $3.55M
• 1 day: -1.77%
• 5 days: -39.27%
• 1 month: -59.13%
• 3 months: -80.86%
• 6 months: -90.73%
• Year to date: -53.47%
• 1 year: -90.73%
• 5 years: -90.73%
• 10 years: -90.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Employees: 2